… Haroon has received consulting fees from Amgen, AbbVie, Janssen, Eli Lilly and Company,
Novartis, and UCB (less than $10,000 each). Dr. Borenstein has received consulting fees …

… were minimal, the authors claimed that subtle differences in peptide binding between
subtypes, which seem to be driven predominantly by variability in the affinity for C and N-terminal …

Ankylosing spondylitis (AS) was first identified in the late 17th century. 250 years later,
inflammatory spine disease was recognized to be one of the patterns of psoriatic arthritis (PsA). …

… meeting the modified New York criteria who had been monitored prospectively and had at
least 2 sets of spinal radiographs a minimum of 1.5 years apart were included in the study (n = …

… Haroon has received consulting fees, speaking fees, and/ or honoraria from AbbVie, Abbott,
Amgen, Janssen/Johnson & Johnson/Centocor/Ortho Biotech Products, Janssen Biotech, …

… N. Haroon reports grants from the Arthritis Society, nonfinancial support from the Institute
of Clinical Evaluative Sciences, and grants from Toronto General and Western Hospital …

Ankylosing spondylitis (AS) is a common, highly heritable, inflammatory arthritis for which
HLA-B*27 is the major genetic risk factor, although its role in the aetiology of AS remains …

… It has not been validated for use in Hindi, the local language of patients in North India.
The calculation of the final score in SF-36 is complicated. Different societies have differing …

… Seniors with (n = 225,045) and without newly diagnosed diabetes (n = 668,070) between
April 1995 and March 2007 were followed until March 2012 for a new diagnosis of dementia. …

… 2–4 weeks after dose 2), n = 129; and C, T4 (3 months after dose 2), n = 86. Lentiviral particles
used: WT (… P values and Spearman’s rho coefficients are indicated in each graph, n = 337. …